Efficacy and safety of bifid triple viable plus aminosalicylic acid for the treatment of ulcerative colitis: A systematic review and meta-analysis

OBJECTIVE: Ulcerative colitis (UC), one of the most stubborn diseases, is mainly treated by aminosalicylic acid (ASA). However, the side effects of ASA include vomiting, nausea, rash, diarrhea, headache, etc, which seriously affect life-quality of UC patients. Probiotics such as bifid triple viable...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Mu-yuan, Qiu, Zhen-wen, Tang, Hong-mei, Zhuang, Kun-hai, Cai, Qing-qun, Chen, Xin-lin, Li, Hui-biao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882635/
https://www.ncbi.nlm.nih.gov/pubmed/31764796
http://dx.doi.org/10.1097/MD.0000000000017955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882635/
https://www.ncbi.nlm.nih.gov/pubmed/31764796
http://dx.doi.org/10.1097/MD.0000000000017955

Ejemplares similares